Breast Imaging Market Soaring at 8.5% CAGR to Register $US 4.14 Billion by 2021

Share this news:

The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021 while North America is estimated to command the largest share of 43.8% of the global breast imaging market in 2016, followed by Europe.



A number of factors such as rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities.

Complete report on Breast Imaging Market spread across 150 Pages, Profiling 10 Companies and Supported with 107 Tables and 39 Figures is now available at http://www.rnrmarketresearch.com/breast-imaging-technologies-market-digital-mammography-3d-breast-tomosynthesis-breast-mri-breast-ultrasound-molecular-breast-imaging-optical-imaging-petctpem-modalities-technology-and-marke-market-report.html .

On basis of type, global breast imaging market is segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight sub segments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography.

Global Breast Imaging Market, by Type

• Ionizing Breast Imaging Technologies
• Analog Mammography
• Full-field Digital Mammography (FFDM)
• 3D Breast Tomosynthesis
• Positron Emission Tomography/Computed Tomography (PET/CT)
• Molecular Breast Imaging/Breast-specific Gamma Imaging (MBI/BSGI)
• Cone-beam Computed Tomography (CBCT)
• Positron Emission Mammography (PEM)
• Electric Impedance Tomography

Non-ionizing breast imaging market technologies segment is classified into five subsegments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging. Automated whole-breast ultrasound (AWBU) segment is expected to grow at highest CAGR in next five years, owing to benefits like high reproducibility, high resolution power with 3D capability, lower false positives, and faster imaging.

Emerging countries, including China and India, are expected to offer significant growth opportunities to market players in coming years. Growth in these markets will majorly be driven by rising incidence of breast cancer and significant investments by governments and leading players in emerging countries.

Sample Copy of this research is Available Now
http://www.rnrmarketresearch.com/contacts/request-sample?rname=68046 .

Breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, & Rest of the World. In 2016, North America is estimated to dominate breast imaging market, majorly due to rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in U.S., rapid growth in geriatric population, and growing demand for use of low levels or negligible radiation doses in region.

In Breast imaging market report, 3D breast tomosynthesis segment is expected to grow at highest CAGR in next five years, owing to increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems.

Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the key players operating in the global breast imaging market.

Visit for more details, queries, corporate discount and other Information on this study “Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=68046 .

Report will enrich both established firms & new entrants/smaller firms to gauge pulse of market, which in turn will help firms in garnering a greater market share. Firms purchasing report could use any one or combination of below-mentioned five strategies (market penetration, product development/innovation, breast imaging market development, market diversification, and competitive assessment) for strengthening their market shares.

Emerging countries, including China and India, are expected to offer significant growth opportunities to market players in the coming years. Growth in these markets will majorly be driven by rising incidence of breast cancer and significant investments by governments and leading players in emerging countries.

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RnR Market Research
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
Phone: +1-888-391-5441
Website: http://www.rnrmarketresearch.com

Release ID: 134417

CONTACT ISSUER
Name: Ritesh Tiwari
Email: Send Email
Organization: RnR Market Research
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
SUBSCRIBE FOR MORE